SMARCB1‐Deficient Pulmonary Mesenchymal Tumor Without Malignant Histological Features
Pathology International · 2025
DOI: 10.1111/pin.70025 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pathology International, 2025. Verfasst von Nozomi Nakajima und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Pathology, Gunma University Graduate School of Medicine, Maebashi, Japan. Hauptthemen laut MEDLINE: SMARCB1 Protein, Lung Neoplasms, Mesenchymoma. Die Arbeit nennt 17 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Complete loss of nuclear SMARCB1 expression was originally described as a hallmark of malignant rhabdoid tumors, typically occurring in the kidney, soft tissue, and central nervous system (CNS). Generally, SMARCB1 deficiency is associated with malignant histopathological appearance, except for some rare tumors. Herein, we present a case of hitherto undescribed SMARCB1‐deficient pulmonary mesenchymal tumor without rhabdoid features or malignant histopathology involving a 62‐year‐old male patient. Histologically, the tumor demonstrated a moderately cellular proliferation of monomorphic spindle cells arranged in short fascicles or a storiform pattern with intervening collagenous stroma. The mitotic activity was lower than that of typical SMARCB1‐deficient tumors, and rhabdoid features and necrosis were absent. Nuclear SMARCB1 expression was lost, and a part of SMARCB1 was revealed to be homozygously deleted. DNA methylation analysis demonstrated that this case was not clustered with other well‐known SMARCB1‐deficient tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Pathology, Gunma University Graduate School of Medicine, Maebashi, Japan.
- Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
- Division of General Thoracic Surgery, Integrative Center of General Surgery, Gunma University Hospital, Maebashi, Japan.
- Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
ORCID-Profile: Yoichi Ohtaki, Nozomi Matsumura, Sumihito Nobusawa
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Nakajima, N., Fukuoka, K., Nakazawa, S., Ohtaki, Y., Matsumura, N., Yamazaki, A., Yokoo, H., Yoshida, A., & Nobusawa, S. (2025). SMARCB1‐Deficient Pulmonary Mesenchymal Tumor Without Malignant Histological Features. Pathology International. https://doi.org/10.1111/pin.70025
Vancouver
Nakajima N, Fukuoka K, Nakazawa S, Ohtaki Y, Matsumura N, Yamazaki A, et al. SMARCB1‐Deficient Pulmonary Mesenchymal Tumor Without Malignant Histological Features. Pathology International. 2025. doi:10.1111/pin.70025
BibTeX
@article{Nakajima2025,
author = {Nakajima, Nozomi and Fukuoka, Kohei and Nakazawa, Seshiru and Ohtaki, Yoichi and Matsumura, Nozomi and Yamazaki, Ayako and Yokoo, Hideaki and Yoshida, Akihiko and Nobusawa, Sumihito},
title = {SMARCB1‐Deficient Pulmonary Mesenchymal Tumor Without Malignant Histological Features},
journal = {Pathology International},
year = {2025},
doi = {10.1111/pin.70025}
}
EUVIMED